HC Wainwright & Co. Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $20
Benzinga · 01/29 11:28
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and announces Price Target of $20.